| Application no. and date | 21835087.4 (espacenet) (Federated) (European Patent Register), 20211206 | | Patent/reg. no. and date | DK/EP 4255397, 20260218 | | Publication date | 20231011 | | Priority no. and date | US 202063199078 P, 20201204 | | EP pub. no. and date |
EP 4255397 20231011 | | Effective date | | | Applicant/owner | Ardelyx, Inc., 34175 Ardenwood Blvd.
Fremont, California 94555, US,
AstraZeneca AB, Forskargatan 18
151 85 Södertälje, SE | | Applicant ref. no. | V2604-031-DK | | Inventor | GUNNARSSON, Cecilia,
431 50 Mölndal, SE,
SWENSON, Magnus,
151 85 Sodertélje, SE,
MATIC, Hanna,
151 85 Sodertélje, SE,
SALOMONSSON, John,
151 85 Sodertélje, SE,
KARLSSON, Eva,
151 85 Sodertélje, SE | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) | | Title | ORALE FORMULERINGER AF TENAPANOR | | Int. application no. | US2021062069 | | Int. publication no. | WO2022120287 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
